Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1993 2
1994 5
1995 10
1996 9
1997 5
1998 5
1999 2
2000 4
2001 5
2002 5
2003 6
2004 4
2005 6
2006 15
2007 21
2008 19
2009 29
2010 28
2011 46
2012 45
2013 31
2014 23
2015 27
2016 24
2017 41
2018 36
2019 34
2020 45
2021 41
2022 31
2023 32
2024 25
2025 23
2026 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

609 results

Results by year

Filters applied: . Clear all
Page 1
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.
Gay F, Roeloffzen W, Dimopoulos MA, Rosiñol L, van der Klift M, Mina R, Oriol A, Katodritou E, Wu KL, Rodríguez Otero P, Hájek R, Antonioli E, van Duin M, D'Agostino M, Martínez-López J, van Leeuwen-Segarceanu EM, Zamagni E, van de Donk NWCJ, Weisel KC, Pour L, Radocha J, Belotti A, Schjesvold F, Bladé J, Einsele H, Sonneveld P, Boccadoro M, Broijl A. Gay F, et al. Among authors: hajek r. Nat Med. 2026 Apr 6. doi: 10.1038/s41591-026-04282-0. Online ahead of print. Nat Med. 2026. PMID: 41942646
The European CAR-T map-Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies.
Pennings ERA, Thielen FW, Broussais F, Delgado J, Jaeger U, Sanges C, Cabrerizo Y, Roux-Opstaele L, Dreuillet C, Gonzalez-Marcano E, Millán O, Huber B, Clavreul S, Bolaños N, Nier S, Mihályová J, Hájek R, Horňáková M, Doeswijk R, Thieblemont C, Hudecek M, Uyl-de Groot CA, Kersten MJ. Pennings ERA, et al. Among authors: hajek r. Hemasphere. 2026 Mar 5;10(3):e70306. doi: 10.1002/hem3.70306. eCollection 2026 Mar. Hemasphere. 2026. PMID: 41799248 Free PMC article.
Isatuximab, bortezomib, lenalidomide, dexamethasone for multiple myeloma: dynamics of MRD-negativity in the IMROZ study.
Orlowski RZ, Dimopoulos MA, Leleu X, Facon T, Ishida T, Hajek R, Spicka I, Romejko-Jarosinska J, Vorobyev VI, Besemer B, Kalayoglu Besisik S, Robak P, Jelínek T, Goldschmidt H, Martin T, Mohty M, Macé S, Kodas E, Tekle C, Shafer AT, Moreau P. Orlowski RZ, et al. Among authors: hajek r. Blood. 2026 Feb 27:blood.2025030120. doi: 10.1182/blood.2025030120. Online ahead of print. Blood. 2026. PMID: 41758929
Early Mortality with Bispecific Antibody Therapy in RRMM: An IMWG Immunotherapy Database Real-World Analysis.
Tan CR, Usmani SZ, Derkach A, De Menezes Silva Corraes A, Parrondo RD, Ailawadhi S, Asoori S, Dave M, Popat R, Morjaria O, Hajek R, Mihalyova J, Htut M, Janakiram M, Visram A, Kastritis E, Dimopoulos MA, Martínez-López J, Nagarajan C, Bal S, Costa LJ, Einsele H, Steinbrunn T, Waldschmidt JM, Riedhammer C, Banerjee R, Chng WJ, Tso AC, Lin Y, Martin TG, Mian H. Tan CR, et al. Among authors: hajek r. Blood Adv. 2026 Feb 24:bloodadvances.2025019231. doi: 10.1182/bloodadvances.2025019231. Online ahead of print. Blood Adv. 2026. PMID: 41734378
Indirect treatment comparison of DVRd plus DR maintenance (PERSEUS study) versus DVTd or VTd with or without lenalidomide maintenance in transplant-eligible patients with previously untreated multiple myeloma.
Dimopoulos MA, Boccadoro M, Einsele H, Rodriguez-Otero P, Hulin C, Perrot A, Leleu X, Caillot D, Facon T, Mina R, Gay F, Broijl A, Hajek R, Spencer A, Schjesvold F, Zweegman S, Nair S, Ammann E, He J, Nobrega M, Rowe M, Sitthi-Amorn A, Sonneveld P. Dimopoulos MA, et al. Among authors: hajek r. J Med Econ. 2026 Dec;29(1):421-430. doi: 10.1080/13696998.2026.2624972. Epub 2026 Feb 17. J Med Econ. 2026. PMID: 41701105 Free article. Clinical Trial.
Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights.
Brodsky AL, Asare A, Fellman B, Anderson K, Yao J, Lee S, Tran H, Xu X, Liu J, Celestino J, Hajek RA, Morgan MB, Mohammad M, Soliman P, Shafer A, Sood AK, Bodurka D, Fleming ND, Onstad Grinsfelder M, Milojevic L, Jazaeri AA, Mills GB, Coleman RL, Westin SN. Brodsky AL, et al. Among authors: hajek ra. Clin Cancer Res. 2026 Apr 1;32(7):1234-1245. doi: 10.1158/1078-0432.CCR-25-1616. Clin Cancer Res. 2026. PMID: 41528970 Free PMC article. Clinical Trial.
Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data Analysis.
Puig N, Leleu X, Lee HC, Davies FE, Hájek R, Hungria V, Thompson MA, Cook G, Ojeda JV, Weisel KC, Berdeja JG, Usmani SZ, Symeonidis A, Nascimento-Ferreira I, Arthur D, Mokrá L, Ren K, Cherepanov D, Terpos E. Puig N, et al. Among authors: hajek r. Eur J Haematol. 2026 Apr;116(4):458-470. doi: 10.1111/ejh.70079. Epub 2026 Jan 13. Eur J Haematol. 2026. PMID: 41528195 Free PMC article.
Winners take it all: turning cell competition into a therapeutic ally.
Fantová T, Warmuzová M, Charvátová S, Stošková K, Jelínek T, Šimíček M, Hájek R, Bagó JR. Fantová T, et al. Among authors: hajek r. Cell Commun Signal. 2026 Jan 7;24(1):87. doi: 10.1186/s12964-025-02611-3. Cell Commun Signal. 2026. PMID: 41501809 Free PMC article. Review.
609 results